학술논문
The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study
Document Type
Article
Author
Source
In: Cancer Discovery . (Cancer Discovery, 1 August 2023, 13(8):1802-1813)
Subject
Language
English
ISSN
21598290
21598274
21598274